is there a patent on semaglutide Ozempic's problem: how Novo Nordisk lost control of blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Brazilian federal court denies semaglutide

10.1186/s40659-018-0157-8 Summary Keywords berberine, renal diseases, inflammation, oxidative stress, apoptosis Citation Fan Z, Wei X, Zhu X, Yang K, Tian L, Wang X, Du Y and Yang L (2025) Unveiling the therapeutic potential of berberine: its therapeutic role and molecular mechanisms in kidney diseases

10.4331/wjbc.v5.i1.68 36 StorzG.TartagliaL

Parker, G

When a therapeutic target can be addressed by either a small-molecule drug or a biologic (antibody, bispecific, ADC), the 4-year extension of the pre-negotiation window creates a clear financial argument for the biologic format

Those who reported the poorest quality of sexual functioning before surgery had the most dramatic improvements a year after

BPC-157 is a popular peptide with impressive animal data, but theres almost zero human data behind it